BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

• Zeynep Eroglu,
• Joe Ensor,
• Meenakshi Malhotra,
• Paul Billings,
• Angel Rodriguez,
• Alexey Aleshin,
• Ling Gao,
• Sarah Sawyer,
• Pashtoon Murtaza Kasi,
• Sascha Ellers,
• George Ansstas,
• Michael Krainock,
• Sakti Chakrabarti,
• Andrew Poklepovic,
• Minu Maninder

Affiliations

Zeynep Eroglu

Departments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Center Inc, Tampa, Florida, USA

Joe Ensor

Houston Methodist Research Institute, Houston, Texas, USA

Meenakshi Malhotra

Scientific Affairs, Natera Inc, San Carlos, California, USA

Paul Billings

Natera Inc, San Carlos, California, USA

Angel Rodriguez

Natera Inc, San Carlos, California, USA

Alexey Aleshin

Natera Inc, San Carlos, California, USA

Ling Gao

Department of Cardiology, Chengdu University of Traditional Chinese Medicine Affiliated Fifth People`s Hospital, Chengdu, Sichuan, China

Sarah Sawyer

Natera Inc, San Carlos, California, USA

Pashtoon Murtaza Kasi

Department of Oncology/Hematology, Division of Internal Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USA

Sascha Ellers

Natera Inc, San Carlos, California, USA

George Ansstas

1Washington University in Saint Louis, St. Louis, MO, USA

Michael Krainock

Natera Inc, San Carlos, California, USA

Sakti Chakrabarti

Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Andrew Poklepovic

VCU Health System Massey Cancer Center, Richmond, Virginia, USA

Minu Maninder

Natera Inc, Austin, Texas, USA